Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
MBAI stock price ended at $1.71 on 화요일, after dropping 2.29%
On the latest trading day Feb 10, 2026, the stock price of MBAI fell by 2.29%, dropping from $1.73 to $1.71. During the session, the stock saw a volatility of 8.38%, with prices oscillating between a daily low of $1.67 and a high of $1.81. On the latest trading day, the trading volume for MBAI decreased by 68.1K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 78.7K shares were traded, with a market value of approximately $12.0M.
MBAI 기술적 시그널
기술적 시그널 요약
구매 신호 2
중립 신호 2
매도 신호 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
MBAI은 현재 2개의 매수 신호와 3개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 하락 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 -2.29%입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
MBAI에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 MBAI 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.